Loading Events

« All Events

Washington Case Conference

March 8, 2024 — 12:00 pm - 2:00 pm EST

Registration Link:

The Emerging Field of Psychedelic-Assisted Psychotherapy


Psychedelic therapies have garnered much enthusiasm in recent years as potential
breakthrough treatments for a variety of mental health conditions. This presentation will
describe the current state of the field of psychedelic-assisted psychotherapy, explore proposed
mechanisms of psychedelics’ therapeutic action; and detail ethical implications of psychedelic
therapies as they become more broadly accessible.

Gregory Barber, MD, is a psychiatrist and psychodynamic therapist in private practice in
North Bethesda, MD. He has published several articles on psychedelic-assisted
psychotherapy and is also a member of the American Psychiatric Association’s Ethics
Committee, where he chaired the Psychedelics and Novel Therapeutics Workgroup.

Learning Objectives:
1. Explain the structure of psychedelic therapies.
2. Discuss how psychedelics work, from both neurocognitive and psychological
3. Describe ethical issues related to psychedelic therapies, including informed
consent, patient vulnerability, and equity and access.

– Jeffrey Guss (2022) A Psychoanalytic Perspective on Psychedelic Experience, Psychoanalytic
Dialogues, 32:5, 452-468, DOI: 10.1080/10481885.2022.2106140
– Carhart-Harris RL, Friston KJ. REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of
Psychedelics. Pharmacol Rev. 2019 Jul;71(3):316-344. doi: 10.1124/pr.118.017160. PMID: 31221820; PMCID:
– Barber G, Dike C. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry. Psychiatric
Services. 2023 Mar 29:appips20220525. doi: 10.1176/appi.ps.20220525.


March 8, 2024
12:00 pm - 2:00 pm EST
Event Category:


By Zoom
Scroll to Top